Dyno Therapeutics
PrivateLast Round
Series A
May 6, 2021
Est. Valuation
$539.27M
Total Funding Raised
$109M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Dyno Therapeutics operates in Healthcare & Life Sciences and is based in Watertown, Massachusetts. Its latest recorded funding round was a Series A round in May 2021.
Dyno Therapeutics is a biotechnology company that provides advanced technologies for innovative gene therapies through its AI-driven platform, which integrates next-generation DNA synthesis of AAV capsids with high-throughput sequencing and machine learning to facilitate safe and efficient in vivo delivery of novel AAV vectors for medical research.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Medical AI
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Infrastructure
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Dyno Therapeutics Comparables
Compare Dyno Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Capsida Biotherapeutics | 83% | |
| Shape Therapeutics | 81% | |
| Voyager Therapeutics | 78% |
For institutional investors. Book with your work email.
Dyno Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | May 6, 2021 | ||||
| Seed | Nov 1, 2018 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Dyno Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Andreessen Horowitz | Series A |
| GV | Series A |
| Lux Capital | Series A |
| Obvious Ventures | Series A |
| CRV | Series A, Seed |
| Casdin Capital | Series A |
| Polaris Partners | Series A, Seed |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 26, 2026
Launched external-facing AI platform for biological design.
- Mar 18, 2026
Open release of curated synthetic domain interfaces dataset.
For institutional investors. Book with your work email.
Dyno Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Dyno Therapeutics's valuation, stock price, and market status.
Is Dyno Therapeutics a public or private company?
Dyno Therapeutics is a private company.
What is the current stock price of Dyno Therapeutics?
Dyno Therapeutics is a private company, so its shares have no public market price. Caplight tracks Dyno Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Dyno Therapeutics worth (valuation)?
Dyno Therapeutics's valuation is estimated at $539.3M based on funding round data.
Can I buy Dyno Therapeutics stock?
Dyno Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Dyno Therapeutics's last funding round?
Dyno Therapeutics's most recent funding round was Series A on May 6, 2021.
Who are the main investors in Dyno Therapeutics?
Key investors in Dyno Therapeutics include Andreessen Horowitz, CRV, Polaris Partners.
Will Dyno Therapeutics IPO soon?
No public IPO plans have been announced for Dyno Therapeutics.
How can I track Dyno Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Dyno Therapeutics's shares on secondary markets.